MTNB
Price
$0.93
Change
+$0.05 (+5.68%)
Updated
Jun 6 closing price
Capitalization
4.73M
SPRC
Price
$0.31
Change
-$0.01 (-3.12%)
Updated
Jun 6 closing price
Capitalization
3.5M
Interact to see
Advertisement

MTNB vs SPRC

Header iconMTNB vs SPRC Comparison
Open Charts MTNB vs SPRCBanner chart's image
Matinas Biopharma Holdings
Price$0.93
Change+$0.05 (+5.68%)
Volume$139.16K
Capitalization4.73M
SciSparc
Price$0.31
Change-$0.01 (-3.12%)
Volume$131.76K
Capitalization3.5M
MTNB vs SPRC Comparison Chart
Loading...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTNB vs. SPRC commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTNB is a Buy and SPRC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (MTNB: $0.93 vs. SPRC: $0.31)
Brand notoriety: MTNB and SPRC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTNB: 73% vs. SPRC: 5%
Market capitalization -- MTNB: $4.73M vs. SPRC: $3.5M
MTNB [@Biotechnology] is valued at $4.73M. SPRC’s [@Biotechnology] market capitalization is $3.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whileSPRC’s FA Score has 1 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • SPRC’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than SPRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTNB’s TA Score shows that 5 TA indicator(s) are bullish while SPRC’s TA Score has 7 bullish TA indicator(s).

  • MTNB’s TA Score: 5 bullish, 3 bearish.
  • SPRC’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SPRC is a better buy in the short-term than MTNB.

Price Growth

MTNB (@Biotechnology) experienced а +14.10% price change this week, while SPRC (@Biotechnology) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

MTNB is expected to report earnings on Apr 15, 2025.

SPRC is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTNB($4.73M) has a higher market cap than SPRC($3.5M). MTNB YTD gains are higher at: 82.333 vs. SPRC (-13.333). SPRC has higher annual earnings (EBITDA): -5.31M vs. MTNB (-21.05M). MTNB has more cash in the bank: 10.8M vs. SPRC (2.08M). SPRC has less debt than MTNB: SPRC (76K) vs MTNB (3.07M). SPRC has higher revenues than MTNB: SPRC (2.88M) vs MTNB (0).
MTNBSPRCMTNB / SPRC
Capitalization4.73M3.5M135%
EBITDA-21.05M-5.31M396%
Gain YTD82.333-13.333-617%
P/E RatioN/A0.00-
Revenue02.88M-
Total Cash10.8M2.08M520%
Total Debt3.07M76K4,041%
FUNDAMENTALS RATINGS
MTNB: Fundamental Ratings
MTNB
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MTNBSPRC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBS6.630.58
+9.59%
Emergent Biosolutions
SIGA6.030.15
+2.55%
SIGA Technologies
AFG125.162.10
+1.71%
American Financial Group
BOH66.951.05
+1.59%
Bank of Hawaii Corp
ZCMD1.080.01
+0.55%
Zhongchao

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with EQ. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then EQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
+6.01%
EQ - MTNB
37%
Loosely correlated
+4.80%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
-1.88%
AXON - MTNB
34%
Loosely correlated
+1.52%
VKTX - MTNB
32%
Poorly correlated
+2.92%
More

SPRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRC has been loosely correlated with ASMB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRC jumps, then ASMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRC
1D Price
Change %
SPRC100%
-1.88%
ASMB - SPRC
45%
Loosely correlated
+2.72%
GYRE - SPRC
38%
Loosely correlated
+5.52%
MTNB - SPRC
36%
Loosely correlated
+6.01%
ALZN - SPRC
31%
Poorly correlated
-2.69%
UBX - SPRC
31%
Poorly correlated
-1.02%
More